Title : Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44.

Pub. Date : 2020 Mar 6

PMID : 31841994






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), such as gefitinib, have been established as first-line treatments for non-small cell lung cancer (NSCLC) patients and have exhibited notable clinical efficacy. Tyrosine epidermal growth factor receptor Homo sapiens
2 Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), such as gefitinib, have been established as first-line treatments for non-small cell lung cancer (NSCLC) patients and have exhibited notable clinical efficacy. Tyrosine epidermal growth factor receptor Homo sapiens